Objective@#This article aims to present a brief profile of the advances in prevention and
treatment of myocardial
injury in
cancer therapy based on relevant
literature or
reports.@*
Data sources@#The data cited in this
review were obtained from articles indexed in
PubMed and
China National
Knowledge Internet (CNKI) up to June 2019.@*Study selection@#Articles were selected with the following
keywords "Anti-
cancer therapy," "Myocardial
injury," "
Breast cancer," "
Echocardiography," and "
Chemotherapy."@*Results@#Due to the rapid development of novel
cancer therapeutic approaches, the
life expectancy of
tumor patients has been prolonged continuously. Meanwhile, a large number of studies have found that among
patients benefiting from precise management, some medications have exerted direct or indirect side effects on the
cardiovascular system, leading to the occurrence of myocardial
injury. Because there are many common
risk factors between
breast cancer and
cardiovascular disease, and there is a special anatomical position between
breast and
heart, the
cardiology related to
breast cancer patients is relatively unique in onco-
cardiology.@*Conclusions@#
Heart function
monitoring is critical during anti-
cancer therapy so that we can early identify cardiac
abnormalities and actively adopt
measures to prevent myocardial
injury.